Neogen Corporation $NEOG Position Increased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its position in Neogen Corporation (NASDAQ:NEOG) by 23.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 9,132,021 shares of the company’s stock after purchasing an additional 1,733,767 shares during the period. Dimensional Fund Advisors LP’s holdings in Neogen were worth $84,831,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in NEOG. UMB Bank n.a. lifted its holdings in shares of Neogen by 238.2% in the fourth quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock valued at $45,000 after purchasing an additional 4,523 shares in the last quarter. Hantz Financial Services Inc. grew its holdings in shares of Neogen by 816.9% during the fourth quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock valued at $53,000 after buying an additional 6,764 shares in the last quarter. Cresset Asset Management LLC purchased a new position in shares of Neogen during the second quarter valued at $53,000. Evergreen Capital Management LLC acquired a new position in Neogen during the second quarter valued at $56,000. Finally, Northwestern Mutual Wealth Management Co. raised its position in Neogen by 3,158.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock valued at $58,000 after buying an additional 8,054 shares during the period. 96.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on NEOG. Weiss Ratings lowered Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, July 24th. Wall Street Zen upgraded Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.67.

Neogen Trading Up 22.7%

Neogen stock opened at $11.53 on Friday. Neogen Corporation has a 12 month low of $4.56 and a 12 month high of $11.56. The company has a quick ratio of 2.84, a current ratio of 3.92 and a debt-to-equity ratio of 0.38. The stock has a market cap of $2.51 billion, a P/E ratio of -4.12, a P/E/G ratio of 4.21 and a beta of 1.80. The company’s fifty day simple moving average is $9.37 and its 200-day simple moving average is $9.60.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.04. The business had revenue of $225.30 million during the quarter, compared to analyst estimates of $212.35 million. Neogen had a positive return on equity of 2.35% and a negative net margin of 69.93%.Neogen’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the company earned ($2.82) earnings per share. As a group, sell-side analysts forecast that Neogen Corporation will post 0.23 EPS for the current fiscal year.

Key Headlines Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Quarterly results exceeded expectations: Neogen reported fiscal Q4 earnings of $0.09 per share, versus the $0.05 consensus estimate, while revenue of $225.3 million surpassed expectations of $212.35 million. The earnings result also improved substantially from the prior-year loss. Neogen Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Above-consensus outlook: Management forecast fiscal 2027 revenue of $880 million to $885 million, well above the roughly $851.1 million analyst consensus. First-quarter fiscal 2027 revenue guidance of $207 million to $209 million also topped the $204.9 million consensus. The company outlined adjusted EBITDA guidance of $180 million to $182 million for fiscal 2027. Neogen Fiscal 2027 Outlook
• Neutral Sentiment: Investment may weigh on near-term profitability: Neogen plans to increase research and development spending by about 50%, signaling continued investment in future growth but potentially limiting margin expansion in the near term. Neogen Q4 Earnings Call Transcript
• Negative Sentiment: Revenue growth remained muted: Fiscal Q4 revenue was essentially flat year over year, declining 0.1%, so the stock’s positive reaction depends heavily on the earnings beat and forward guidance rather than current top-line growth.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user?friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.